Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC28548785;8786;8787 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
N2AB28548785;8786;8787 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
N2A28548785;8786;8787 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
N2B28088647;8648;8649 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
Novex-128088647;8648;8649 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
Novex-228088647;8648;8649 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866
Novex-328548785;8786;8787 chr2:178770141;178770140;178770139chr2:179634868;179634867;179634866

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAG
  • RefSeq wild type template codon: GTC
  • Domain: Ig-18
  • Domain position: 60
  • Structural Position: 141
  • Q(SASA): 0.2758
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/H None None 0.028 N 0.164 0.271 0.238096912614 gnomAD-4.0.0 6.84063E-07 None None None None N None 0 0 None 0 0 None 0 0 0 0 1.65574E-05
Q/R rs750346528 None 0.801 N 0.413 0.317 0.231873229951 gnomAD-4.0.0 1.59047E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 3.02133E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.3253 likely_benign 0.4295 ambiguous -0.441 Destabilizing 0.842 D 0.344 neutral None None None None N
Q/C 0.7022 likely_pathogenic 0.8054 pathogenic 0.052 Stabilizing 0.998 D 0.517 neutral None None None None N
Q/D 0.4943 ambiguous 0.6427 pathogenic -1.014 Destabilizing 0.842 D 0.361 neutral None None None None N
Q/E 0.1129 likely_benign 0.1295 benign -0.918 Destabilizing 0.625 D 0.359 neutral N 0.502341142 None None N
Q/F 0.7722 likely_pathogenic 0.8625 pathogenic -0.254 Destabilizing 0.949 D 0.516 neutral None None None None N
Q/G 0.3581 ambiguous 0.456 ambiguous -0.799 Destabilizing 0.842 D 0.437 neutral None None None None N
Q/H 0.2271 likely_benign 0.3356 benign -0.878 Destabilizing 0.028 N 0.164 neutral N 0.479643097 None None N
Q/I 0.5408 ambiguous 0.6595 pathogenic 0.468 Stabilizing 0.904 D 0.464 neutral None None None None N
Q/K 0.1324 likely_benign 0.1591 benign -0.297 Destabilizing 0.801 D 0.382 neutral N 0.494406951 None None N
Q/L 0.1976 likely_benign 0.2625 benign 0.468 Stabilizing 0.012 N 0.253 neutral N 0.504073255 None None N
Q/M 0.4662 ambiguous 0.5781 pathogenic 0.991 Stabilizing 0.949 D 0.408 neutral None None None None N
Q/N 0.3395 likely_benign 0.4679 ambiguous -0.885 Destabilizing 0.842 D 0.353 neutral None None None None N
Q/P 0.3827 ambiguous 0.529 ambiguous 0.197 Stabilizing 0.989 D 0.432 neutral N 0.510244506 None None N
Q/R 0.1396 likely_benign 0.1604 benign -0.29 Destabilizing 0.801 D 0.413 neutral N 0.494583541 None None N
Q/S 0.3309 likely_benign 0.4211 ambiguous -0.904 Destabilizing 0.842 D 0.319 neutral None None None None N
Q/T 0.2911 likely_benign 0.3802 ambiguous -0.619 Destabilizing 0.915 D 0.383 neutral None None None None N
Q/V 0.3735 ambiguous 0.4758 ambiguous 0.197 Stabilizing 0.728 D 0.416 neutral None None None None N
Q/W 0.6328 likely_pathogenic 0.7274 pathogenic -0.21 Destabilizing 0.998 D 0.515 neutral None None None None N
Q/Y 0.5374 ambiguous 0.6837 pathogenic 0.08 Stabilizing 0.949 D 0.414 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.